Search results
Results From The WOW.Com Content Network
Specimen provenance complications (SPCs) result from instances of biopsy specimen transposition, extraneous/foreign cell contamination or misidentification of cells used in clinical or anatomical pathology. If left undetected, SPCs can lead to serious diagnostic mistakes and adverse patient outcomes.
Weight fraud (also scale fraud and short-weighting) is a type of measurement fraud involving the mislabeling or inaccurate weighing of products. In this deceptive practice, products are labeled or weighed in a manner that falsely indicates a greater weight than they actually possess.
The pipetting and washing systems in an automated analyzer are designed to continuously cycle between the aspiration of patient specimens and cleaning. An obvious concern is a potential for carryover of analyte from one patient specimen into one or more following patient specimens, which can falsely increase or decrease the measured analyte ...
The most credible average mislabeling rate at the product-level was 8% (95% HDI: 4–14%). The authors make the important point that low mislabeling rates do not necessarily translate to no impacts; rather, mislabeling rates must combined with other data in order to understand the extent and potential consequences of mislabeling.
Drugs and medical devices are typically recalled if the product is defective, contaminated, contains a foreign object, fails to meet specifications, mislabeled, or misbranded. [8] Misbranding was the most common reason for pharmaceutical recalls in 2015, accounting for 42%.
A federal judge has ordered a Florida Keys fish exporter to pay a $250,000 fine and placed the company on five years of probation for falsely labeling seafood it sent to China as Florida spiny ...
For the first 20 years, plastination was used to preserve small specimens for medical study. In the early 1990s, the equipment was developed to make plastinating whole body specimens possible, each specimen taking up to 1,500-man-hours to prepare. [35] The first exhibition of whole bodies was displayed by von Hagens in Japan in 1995.
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail ...